Antiangiogenic and anticancer activity of saponins of Momordica cymbalaria

Background: The aim of the current study was to evaluate invitro anticancer activity of saponins of MC on EAC cells by using cytotoxicity (MTT) assay. To evaluate in vivo antiangiogenic potential of saponins of MC on rat air sac angiogenesis, EAC induced peritoneal angiogenesis, CAM angiogenesis. Methods: MTT assay was carried out at different concentrations of saponins of MC in 12 microliter plates containing media with EAC cells. In rat air sac angiogenesis, carrageenin was injected (s.c.) into the air sac. Dexamethasone, indomethacin, saponins of MC was administered to identify the angiogenic activity. In EAC induced angiogenesis in peritoneum, EAC cells were administered through i.p in mice peritoneum. 5-fluoro uracil, (i.p) and saponins of MC (orally) was given to identify angiogenic activity. In CAM angiogenesis, erythropoietin was given to eggs on 8th day of incubation. saponins were given on the 12th day for two days to observe the antiangiogenic activity. Results: The observed cytotoxic effects of saponins of MC on EAC cells find statistically significant. There is significant reduction in vascular branching in rat air sac model; EAC induced peritoneal angiogenesis, CAM model by the saponins of MC. Conclusions: Due to lack of certain records, it is envisaged that the change of medicine both discontinuation as well as addition was done because of blood glucose control, cost factor [in case of pioglitazone] as well as patient’s compliance. [Int J Basic Clin Pharmacol 2014; 3(1.000): 70-78]